The Medicine Maker | The Medicine Maker

Video: Sitting Down With… John Tomtishen

October 7, 2026

Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization

1 min read

Cell & Gene

Pregnancy After CAR T Shows Early Promise

No autoimmune disease flares occurred across 14 pregnancies after CAR T-cell therapy, with 8 healthy babies born and 5 pregnancies ongoing.

Industry News

Building a Pre-Disease Data Map

Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear

Cell & Gene

Building a CAR-T CMC Strategy on a Limited Budget

Early developers do not need a finalized commercial process before first-in-human studies, but they do need a clear plan for managing cost, scalability, comparability, and future manufacturing changes

Development & Clinical

Musings from The Power List: Andres Sirulnik

Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

View Profile

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

View Profile

Musings from The Power List: Claudia Zylberberg

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

Read the article

All the latest Medicine Maker articles.

Supply Chain Future of Pharma Business & Trends Power List

The Resilience Prescription

October 2, 2026

We asked the 2026 Power List how the pharmaceutical industry can prepare for geopolitical, economic, regulatory, and scientific uncertainty

5 min read

Supply Chain Business & Trends

Video: From Accounting to Action on Pharma Sustainability

October 2, 2026

Ahead of CPHI Milan’s Sustainability Summit, Silvia Forroova and Rob Williams discuss how shared standards and supplier partnerships can turn commitments into measurable progress.

1 min read

Development & Clinical Cell & Gene Interviews Business & Trends Technology & Manufacturing Power List

Musings from The Power List: Fabian Gerlinghaus

October 1, 2026

Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made

3 min read

Cell & Gene Sponsored

In vivo CAR‑T – Reimagining Immune Engineering with Direct Cell Reprogramming

September 30, 2026

How direct T-cell reprogramming could simplify CAR-T manufacturing, expand patient access, and extend cellular immunotherapy to new indications

10 min read

Cell & Gene Industry News

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

September 30, 2026

Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated children with a natural history cohort

2 min read

Development & Clinical Future of Pharma

How Companion Diagnostics Can Support Targeted Drug Launches

September 29, 2026

Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval

5 min read

Cell & Gene Industry News Development & Clinical Research News

Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169

September 28, 2026

Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma

3 min read

Biopharma Development & Clinical Interviews Business & Trends Power List

Musings from The Power List: Renee Aguiar-Lucander

September 28, 2026

Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner

2 min read

Cell & Gene Business & Trends

Roving Reporter Asks: Is Cell and Gene Therapy Entering a More Mature Phase?

September 25, 2026

IBTV speaks with industry leaders at ASGCT 2026 about the regulatory, manufacturing, investment, and commercialization trends signaling a new phase for advanced therapies

1 min read

Research News Cell & Gene

MAPK Inhibitors Restore CAR T-Cell Target in Thyroid Cancer Models

September 24, 2026

Trametinib and dabrafenib increased TSHR expression and improved the activity of CAR T cells in a patient-derived model of anaplastic thyroid cancer

2 min read

Top Stories